Unprecedented growth opportunity
Download
1 / 30

Unprecedented Growth Opportunity - PowerPoint PPT Presentation


  • 113 Views
  • Updated On :

Unprecedented Growth Opportunity. BIOTECHNOLOGY. Biotechnology. India - An Overview Market and Growth Potential Players Opportunities Why India? Contact in India. India - An Introduction. Over 1 bn 35 3.3 mn sq kms 22 English US$ 534 US$ 650 bn. Population States/UTs

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Unprecedented Growth Opportunity' - skylar


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Slide2 l.jpg

Biotechnology

  • India - An Overview

  • Market and Growth Potential

  • Players

  • Opportunities

  • Why India?

  • Contact in India


Slide3 l.jpg

India - An Introduction

Over 1 bn

35

3.3 mn sq kms

22

English

US$ 534

US$ 650 bn

  • Population

  • States/UTs

  • Geographical Area

  • Languages recognised

  • Business language

  • Per Capita Income**

  • GDP**

**(at factor cost & at current prices)

1USD=43.54 INR (as on July 4, 2005)

Source:CSO Statistics


Slide4 l.jpg

India - Fast pace Growth

  • Largest democracy

  • 4th largest economy by PPP index

  • 6th largest energy consumer

  • ForEx reserves skyrocket from US$ 42 bn (2001) to

    US$ 133 bn (February, 2005)

  • GDP growth to continue between 6-8%

  • 3rd largest economy by 2050: Goldman Sachs

  • Leading in IT & BPO

  • Oil & Gas and Biotechnology sunrise industries


Slide5 l.jpg

India - Leading the world

  • Hero Honda - largest manufacturer of motorcycles

  • Moser Baer - among the top three media manufacturers

    in the world

  • Pharmaceutical Industry - 4th largest in world

  • Walmart, GAP, Hilfiger sources more than

    USD 1bn worth apparel from India

  • 100 Fortune 500 have set R&D facilities in India

    including GE, Delphi, Eli Lilly, HP, Heinz and Daimler

    Chrysler


Slide6 l.jpg

Biotechnology

  • India - An Overview

  • Market and Growth Potential

  • Players

  • Opportunities

  • Why India?

  • Contact in India


Slide7 l.jpg

Biotech Market - Dynamic and growing

  • Size (2004-05) US$ 1090.5 mn

  • Largest segment Biopharma

  • Revenue from exports (2003-04) 56%

  • Total investment (2003-04) US$ 137 million

    Rate of growth over 202-2003 26%


Slide8 l.jpg

Biopharma leads the way

Bio Agri

Bio-IT

6.95%

2.09 %

Bio Services

8.95%

Bio Pharma

75.24 %

Composition of Indian Biotech Sector (2004-05)

Bio Industrial

6.74%

Source:Biospectrum-ABLE Survey


Slide9 l.jpg

Market - A consistent uptrend

25% growth in investment

2002-03

70% growth in employment

74% growth in R&D

manpower

US$ 5 billion annual

revenues

2010

1 million skilled jobs

10% of global industry

Source: Confederation of Indian Industry (CII)


Slide10 l.jpg

Biotechnology

  • India - An Overview

  • Market and Growth Potential

  • Players

  • Opportunities

  • Why India?

  • Contact in India




Slide13 l.jpg

Biotechnology

  • India - An Overview

  • Market and Growth Potential

  • Players

  • Opportunities

  • Why India?

  • Contact in India


Slide14 l.jpg

Investments

  • Annual investments in this sector will be of the order of US$ 150 mn and are growing at the rate of 25%.

  • An additional investment of US$ 216 mn is expected in FY2005


Slide15 l.jpg

Invest in Biopharmaceuticals

  • Vaccine Sales of US$ 383.6 mn (2004-05)

  • Therapeutic Marketing licenses granted for

    over 25 recombinant therapeutic

    proteins

  • Diagnostics Sales market - US$ 138.2 mn (2004-05)


India the vaccine hub l.jpg
India: The Vaccine Hub

  • Indian firms estimated to supply 90% of global demand for the measles vaccine, in the near future.

  • Serum Institute, Pune is believed to be the world`s largest manufacturer of DPT vaccines.

  • Indian Immunologicals operates the world`s second largest plant for veterinary vaccines and is also the world`s largest manufacturer of the vaccine against Foot and Mouth Disease.


Slide17 l.jpg

Invest in Biopharmaceuticals

  • Therapeutic Accounts for 16.7% of total biopharma

    sales

  • Diagnostics Forecast to grow by 35-40% in 2005

    Immuno diagnostic market to increase

    4 to 5 folds by 2005


Slide18 l.jpg

Invest in Bioinformatics

By 2006 bionformatics market to grow

2004-05 US$ 22.9 mn

By 2006 US$ 120 mn

Source: International Data Corporation (IDC)

  • Data mining

  • Gene annotation

  • Software bioinformatics

    interface development

Opportunities for

investment


Slide19 l.jpg

Invest in Genomics and Industrial Biotech

  • Genomics

  • Industrial Biotech

  • Size (2004-05) US$ 73.5 mn


Slide20 l.jpg

Invest in Agri Biotech

Biofertilisers

Biofuels

GM Crops and seeds

Biopesticides


Slide21 l.jpg

Invest in Agri Biotech

Biofertilisers

Biofuels

GM Crops and seeds

Biopesticides


Slide22 l.jpg

Clinical Trials - Destination India

Quality

Speed

Technology

Disease Profile

Investigators

Genetic diversity

Ethics

Quality guidelines conformed

Patient enrolment rates upto six times higher than US

CROs to benefit from India’s IT

strengths in data management

High incidence of infectious/lifestyle diseases

Excellent pool of qualified & trained doctors and physicians


Slide23 l.jpg

Biotechnology

  • India - An Overview

  • Market and Growth Potential

  • Players

  • Opportunities

  • Why India?

  • Contact in India


Slide24 l.jpg

The India Advantage

Excellent network

of research laboratories

Well-developed

base industries

Rich biodiversity

Extensive clinical trials

opportunities

Trained manpower

and knowledge base


Slide25 l.jpg

The Infrastructure Advantage

  • 40 National Research

    Institutes

  • 300 life sciences

    colleges

  • 120 medical colleges

  • 200 biotech companies

  • 100 teaching hospitals

15,000 scientists

500,000 graduates

per annum

17,500 medical graduates

per annum

Employing 25,000

scientists in R&D

Employing medical &

paramedical professionals


Slide26 l.jpg

The R & D Advantage

Genetic Engineering

DNA technologies

New Drug Delivery Systems

Rational drug design

Stem cell research

Bioinformatics

Biotech

R&D

strengths

spread

across

range of

segments


Slide27 l.jpg

The Policy Advantage

  • India has transitioned from a process patent regime to a product patent regime w.e.f January, 2005

  • 150% weighted deduction on R&D expenditure

  • Single window application processing proposed by DBT

  • New biotech proposals to be cleared within 150 days

  • Formation of a SME Growth Fund to provide equity support to small & medium units in the biotechnology sectors (Union Budget 2005-06)


Slide28 l.jpg

Union Budget 2005-06

The Biotech Park Advantage

  • Benefits enjoyed by Export Oriented Units (EOU) extended to Biotech Parks

    - 100% FDI permitted through automatic route

    - BTP units exempt from payment of Income Tax

    - Export proceeds to be realised within 12 months

    - BTPs allowed to retain 100% export earnings in the EEFC account


Slide29 l.jpg

Biotechnology

  • India - An Overview

  • Market and Growth Potential

  • Players

  • Opportunities

  • Why India?

  • Contact in India


Slide30 l.jpg

Contact in India

Confederation of Indian Industry (CII)

The Mantosh Sodhi Centre

23 Institutional Area

Lodi Road

New Delhi 110003

Tel 0091 11 24629994 - 7

Fax 0091 11 24626149/24615693

E-mail c.banerjee@ciionline.org